A one-minute look back at the week of January 26, 2015, in managed care, including anticipated moves from volume-based to value-based payments and expected push back on cancer drug costs.
This week HHS announced goals and a timeline for shifting Medicare payments from volume to value. Shortly after, a new task force of payers and providers formed to facilitate the transition away from fee-for-service payments.
Novartis reported that it expects payers will begin to push back against cancer drug therapy costs.
And lastly, the Joslin Diabetes Center is partnering with The American Journal of Managed Care to bring to life Patient-Centered Diabetes Care in Boston, Massachusetts, April 16-17.
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Covering antiobesity medications like semaglutide could save Medicare around $500 million annually; preliminary CDC data showed a 3% decline in the number of US overdose deaths last year; the Biden administration recently announced the first national maternal mental health strategy.
Read More
After the ACA Expanded Health Care Access, 2024 Elections May See Voters Demand Affordability
May 15th 2024At the spring conference of the New Jersey Health Care Quality Institute, speakers discussed how health policy, affordability, and transparency may play a role in voters’ decisions.
Read More